These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 23486179)

  • 61. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
    Smith SY; Recker RR; Hannan M; Müller R; Bauss F
    Bone; 2003 Jan; 32(1):45-55. PubMed ID: 12584035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.
    Shahnazari M; Yao W; Dai W; Wang B; Ionova-Martin SS; Ritchie RO; Heeren D; Burghardt AJ; Nicolella DP; Kimiecik MG; Lane NE
    Bone; 2010 May; 46(5):1267-74. PubMed ID: 19931661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats.
    Ammann P; Bourrin S; Bonjour JP; Brunner F; Meyer JM; Rizzoli R
    Osteoporos Int; 1999; 10(5):369-76. PubMed ID: 10591834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats.
    De La Piedra C; Quiroga I; Montero M; Dapia S; Caeiro JR; Rubert M; Diaz-Curiel M; Bauss F
    Aging Male; 2011 Dec; 14(4):220-30. PubMed ID: 20937008
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats.
    Ma L; Ji JL; Ji H; Yu X; Ding LJ; Liu K; Li YQ
    Bone; 2010 Jul; 47(1):5-11. PubMed ID: 20362079
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats.
    Thomsen JS; Mosekilde LI; Gasser JA
    Bone; 1999 Nov; 25(5):561-9. PubMed ID: 10574576
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The preventive and interventional effects of raloxifene analog (LY117018 HCL) on osteopenia in ovariectomized rats.
    Li X; Takahashi M; Kushida K; Inoue T
    J Bone Miner Res; 1998 Jun; 13(6):1005-10. PubMed ID: 9626632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
    Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
    Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of minodronic acid hydrate in patients with steroid-induced osteoporosis.
    Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Ikumi N; Sugiyama K; Nagasawa Y; Karasawa H; Iwata M; Matsukawa Y; Takei M
    Int J Rheum Dis; 2018 Apr; 21(4):813-820. PubMed ID: 26929019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.
    Liu X; Lei W; Wu Z; Cui Y; Han B; Fu S; Jiang C
    Med Eng Phys; 2012 Jan; 34(1):2-8. PubMed ID: 21775186
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.
    Vajda EG; Hogue A; Griffiths KN; Chang WY; Burnett K; Chen Y; Marschke K; Mais DE; Pedram B; Shen Y; van Oeveren A; Zhi L; López FJ; Meglasson MD
    J Bone Miner Res; 2009 Feb; 24(2):231-40. PubMed ID: 18847323
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.